BSE filing, NSE: EMCURE. Summary written from the filing by ALFA Finder's alert engine.
Emcure Pharmaceuticals Ltd: key numbers
- Share price
- ₹1,865.00
- Market cap
- ₹35,381 Cr
- Revenue (annual)
- ₹9,204 Cr
- Net profit (annual)
- ₹924.4 Cr
- P/E (TTM)
- 35.0×Sector 48.7×
- Promoter holding
- 77.82%-0.01% QoQ
- FII holding
- 4.94%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Emcure Pharmaceuticals Ltd
All →Emcure Pharmaceuticals Other Announcement
Emcure Pharmaceuticals submitted its quarterly shareholding pattern for the period ended September 30, 2026. This filing is a routine regulatory compliance disclosure under SEBI.
Emcure Pharmaceuticals Acquisition
Emcure Pharmaceuticals approved the merger of its wholly-owned subsidiaries, Zuventus Healthcare and Emcutix Biopharmaceuticals, into itself. The internal restructuring involves no cash consideration or share issuance.
Emcure Pharmaceuticals Legal & Regulatory
Emcure Pharmaceuticals received Income-tax Department orders imposing aggregate penalties of Rs. 57.74 Crore for assessment years 2015-16 to 2021-22. The company is evaluating legal remedies.
- Value
- ₹57.74 Cr
Emcure Pharmaceuticals Investor Presentation: Key Takeaways
Emcure reported strong Q1 FY27 momentum with revenue of INR 92,035 Mn and PAT of INR 9,413 Mn for FY26. Strategy focuses on chronic-led domestic expansion and differentiated international portfolios.
Emcure Pharmaceuticals Annual General Meeting
Emcure Pharmaceuticals held its 45th Annual General Meeting on September 21, 2026. The meeting transacted ordinary and special business, including the approval of a final dividend.
Emcure Pharmaceuticals Employee Stock Options
Emcure Pharmaceuticals allotted 11,400 equity shares to employees following the exercise of vested options under the ESOP scheme. This increases the company's total issued share capital.
Other board meeting date announcements
All →Ajwa Fun World & Resorts Board Meeting Date
Ajwa Fun World & Resort schedules a 4 November 2026 board meeting for quarterly results and a secretarial auditor appointment. No monetary amount is disclosed.
Prashant India Board Meeting Date
Prashant India Ltd scheduled a board meeting for November 5, 2026, to consider and approve the standalone unaudited financial statements for the quarter ended September 2026.
Metalic Technoforge Board Meeting Date
Metalic Technoforge Limited scheduled a board meeting for November 4, 2026, to consider and approve its unaudited half-yearly financial results.
G G Dandekar Properties Board Meeting Date
G. G. Dandekar Properties Ltd has scheduled a board meeting for November 4, 2026, to approve its financial results for the quarter and half-year ended September 30, 2026.
Jyoti CNC Automation Board Meeting Date
Jyoti CNC Automation Ltd will hold a board meeting on November 03, 2026, to approve standalone and consolidated financial results for the quarter ended September 30, 2026.
Generic Engineering Construction and Projects Board Meeting Date
Generic Engineering Construction and Projects Ltd scheduled a board meeting on November 3, 2026. The meeting will consider standalone and consolidated quarterly financial results.